• Bhubaneswar India
  • Contact+ 91-9938772605
  • Mon - Sat : 10:00AM - 6:00PM

Tag: Sightsavers India

Sightsavers India and AbbVie Host Successful State-Level Glaucoma Awareness Consultation

Bhubaneswar, Odisha – July 02, 2024Sightsavers India, in collaboration with AbbVie India, successfully launched a series of state-level consultations across India to raise awareness about the prevention of visual impairment due to glaucoma. The inaugural event took place at Lemon Tree Premier in Bhubaneswar, Odisha, drawing a diverse audience that included ophthalmologists, senior optometrists, public health professionals, civil society representatives, social scientists, and journalists.

eye awareness

Glaucoma is one of the leading causes of blindness worldwide, and early detection and treatment are critical in preventing visual impairment. This initiative seeks to educate the public, share knowledge among professionals, encourage regular eye check-ups, and promote early detection and treatment.

The consultation commenced with a welcome from Siva Prasad, State Programme Lead, Sightsavers India, Odisha, followed by opening remarks from Mr R.N. Mohanty, Chief Executive Officer of Sightsavers India.

Mr. R.N. Mohanty, Chief Executive Officer of Sightsavers India, emphasized the critical need for early detection and treatment of glaucoma to prevent visual impairment and blindness. “We are dedicated to promoting a culture prioritizing eye health and early intervention. With this aim, we are proud to collaborate with AbbVie India to conduct a series of State-level consultations across India. These consultations will enable vital discussions, bringing to the forefront the issues concerning glaucoma. By initiating dialogue around glaucoma, we empower individuals with the information they need to protect their vision. Our collaboration marks a significant milestone in our efforts to enhance public awareness and prevent avoidable blindness.”

Chief Guest Dr. Mukesh Mahaling, Hon’ble Minister of Health and Family Welfare, Government of Odisha, emphasized the importance of collaborative efforts in tackling glaucoma. He praised the initiative for bringing together expertise and resources to benefit the community.

Mr. Suresh Pattathil, Managing Director & General Manager of AbbVie India (via email) said, “Partnering with Sightsavers India in this initiative reflects our shared commitment to preventing avoidable blindness due to glaucoma and improving eye health across the country. These consultations are pivotal in bringing advanced knowledge and resources to the forefront, ultimately empowering individuals and communities to take proactive steps in managing eye health. We are proud to support this campaign, through which we aim to bridge gaps in understanding and access to care and build a future where sight loss is preventable and manageable.”

Also, during the event two individuals shared their stories about being diagnosed with glaucoma, emphasizing the life-changing impact of early diagnosis and effective management. These personal accounts brought a human element to the discussion, reinforcing the urgency of addressing this public health issue.

The keynote address was delivered by Dr Suneeta Dubey, Medical Director and Director of Glaucoma Services at Dr Shroff’s Charity Eye Hospital, New Delhi. Dr Dubey, a renowned ophthalmologist with over three decades of experience and a pioneer in minimally invasive glaucoma surgeries in India, highlighted the latest advancements in glaucoma treatment and the importance of regular eye screenings.

The panel discussion featured esteemed experts, including Dr Sumita Mohapatra, Professor and Head of the Department at Capital Hospital, Bhubaneswar; Dr Sanghamitra Dash from CARE Hospitals, Bhubaneswar; and Dr N.V. Raghunath Rao of AMRI Hospitals, Bhubaneswar; Basant Mohanty, a Development Professional having Master’s Degree and M.Phil. in Anthropology with specialization in Social Anthropology from Utkal University, Odisha; Dr Jiban Ballav Sarangi, Additional Director for the National Programme for Control of Blindness (NPCB); Dr. Madan Mohan Pradhan, an Applied Epidemiology; and Ms. Minati Singha, a talented and verified journalist, working for The New Indian Express.

The panel deliberated on the topic “Prevention of Visual Impairment Due to Glaucoma,” engaging in an in-depth discussion about the latest advancements in diagnosis, treatment options, and the importance of early detection. Experts shared their experiences and strategies for managing glaucoma, emphasizing the need for regular eye screenings and public awareness. Following the panel discussion, a dynamic Q&A session was conducted, allowing the audience to voice their concerns, ask questions, and contribute their insights. This interactive segment facilitated a rich exchange of ideas, fostering a collaborative atmosphere aimed at enhancing community understanding and involvement in glaucoma prevention.

Mr. Prasannakumar P.N., Director of Programme Operations at Sightsavers India, concluded the event with remarks highlighting the key takeaways and outlining the way forward. He reiterated the commitment to ongoing awareness campaigns and the importance of regular eye check-ups for early detection of glaucoma.

A highlight of the event was the glaucoma screening offered to attendees aged 40 and above, ensuring that participants had access to immediate and practical health benefits from the consultation.

AbbVie India and Sightsavers India Collaborate to Raise Awareness on Glaucoma

New Delhi, 3rd May, 2024: Sightsavers India, a development organisation working to eliminate avoidable blindness and promote equality of opportunity for people with disability, has collaborated with AbbVie Therapeutics India Pvt Limited to spearhead a joint campaign to enhance glaucoma awareness. This often overlooked yet widespread eye ailment impacts millions across India, necessitating urgent attention and education.

Glaucoma, a leading cause of irreversible blindness in the country, affects approximately 1.2 million individuals and contributes to 5.5% of total blindness cases1. Recognising the urgent need to address this public health challenge, Sightsavers India and AbbVie Therapeutics India Pvt Limited India have initiated a concerted campaign to educate the public about glaucoma risk factors, encourage regular eye check-ups, and promote early detection and treatment.

RN Mohanty

The awareness campaign, spanning 15 months, encompasses offline and online activities, including national and regional consultations, glaucoma screening camps, digital outreach through a dedicated microsite and social media promotions, and educational jingles.

Managing Director of AbbVie India, Suresh Pattathil said, “AbbVie India is pleased to partner with Sightsavers India to advance public health, engage diverse audiences, and promote informed decision-making about glaucoma throughout India.

With prevalence rates of glaucoma ranging from 1.7% to 3.5% in individuals aged 40 and above and a staggering 75-80% of cases remaining undiagnosed, the urgency of our collaborative efforts cannot be overstated, and by addressing this, we can progress towards a future where sight loss is preventable and manageable.

Through this concerted campaign, we aim to bridge gaps in understanding and access to care, empowering individuals to take proactive steps in preserving their vision. By shining a spotlight on glaucoma, we aspire to foster a culture where eye health is prioritised, resulting in early detection and treatment.”

CEO of Sightsavers India, RN Mohanty, said, “Our collaboration with AbbVie India signifies a pivotal step forward in our mission to initiate the conversation and enhance understanding surrounding glaucoma in India.

With millions at risk of irreversible blindness due to undiagnosed cases, our joint efforts aim to shed light on the complexities of glaucoma, promoting increased awareness and early detection. Together, we strive to pave the path towards a future where every individual can safeguard their vision and enjoy a life unhindered by preventable sight loss.”

The campaign aims to reach a broad audience across India, particularly individuals aged 40 and above, through targeted outreach efforts and engaging content.

Through their joint initiative, Sightsavers India and AbbVie Therapeutics India Pvt Limited India reaffirm their commitment to promoting eye health and preventing avoidable blindness in India. By raising awareness and fostering community engagement, we endeavour to pave the way towards a world where individuals are well-informed about glaucoma and its associated risks.